Compare $AQB vs $LIMN | Chartloom

Compare

$AQB vs $LIMN

AquaBounty Technologies Inc · Liminatus Pharma Inc

AQB

AquaBounty Technologies Inc

LIMN

Liminatus Pharma Inc

Compare $AQB vs $LIMN

Comparing AquaBounty Technologies Inc and Liminatus Pharma Inc

AQBAquaBounty Technologies Inc

LIMNLiminatus Pharma Inc

AQBAquaBounty Technologies Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

10.5%

52W performance

-47.5%

FCF yield

-132.7%

LIMNLiminatus Pharma Inc

Market cap

$253M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-88.3%

52W performance

-95.3%

FCF yield

-1.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AQB

LIMN

Detailed metrics comparison

AQB

AquaBounty Technologies Inc

LIMN

Liminatus Pharma Inc

Market Cap

AQB$5M

LIMN$253M

Enterprise Value

AQB$4M

LIMN$251M

Price

AQB$1.05

LIMN$3.76

P/E Ratio

AQBN/A

LIMNN/A

P/S Ratio

AQB3.78x

LIMN0.00x

EV/Sales

AQB2.28x

LIMN0.00x

EV/EBITDA

AQB0.00x

LIMN0.00x

P/B Ratio

AQB1.69x

LIMN17.43x

P/FCF Ratio

AQBN/A

LIMNN/A

EV/FCF

AQB-0.49x

LIMN-62.96x

PEG Ratio

AQBN/A

LIMNN/A

Forward P/E (NTM)

AQBN/A

LIMNN/A

Forward P/S (NTM)

AQBN/A

LIMNN/A

Revenue (TTM)

AQB$0

LIMN$0

Revenue Growth (YoY)

AQB-100.0%

LIMNN/A

Forward Rev Growth

AQB0.0%

LIMN0.0%

Gross Margin (TTM)

AQB0.0%

LIMN0.0%

Operating Margin (TTM)

AQB0.0%

LIMN0.0%

EBITDA Margin (TTM)

AQB0.0%

LIMN0.0%

Net Margin (TTM)

AQB0.0%

LIMN0.0%

FCF Margin (TTM)

AQBN/A

LIMNN/A

Net Income (TTM)

AQB$-18M

LIMN$-13M

FCF (TTM)

AQB$-7M

LIMN$-4M

EPS (TTM)

AQB-$3.56

LIMN-$12.94

ROE (TTM)

AQB-4002.0%

LIMN0.0%

ROA (TTM)

AQB-12997.0%

LIMN-62234.0%

ROIC (TTM)

AQB-2623.0%

LIMN0.0%

Cash

AQB$2M

LIMN$3M

Debt

AQB$0

LIMN$1M

Net Cash/Debt

AQB$2M

LIMN$2M

Current Ratio (TTM)

AQB4.26x

LIMN1.12x

Quick Ratio (TTM)

AQB4.22x

LIMN0.99x

Debt/Equity (TTM)

AQB0.21x

LIMN4.80x

Debt/Assets (TTM)

AQB0.0%

LIMN0.0%

Interest Coverage (TTM)

AQBN/A

LIMNN/A

Net Debt/EBITDA (TTM)

AQB0.00x

LIMN0.00x

Beta

AQB1.45

LIMN0.75

52W Performance

AQB-47.5%

LIMN-95.3%

YTD Performance

AQB10.5%

LIMN-88.3%

% from 52W High

AQB-48.5%

LIMN-97.3%

% from 52W Low

AQB35.6%

LIMN14.3%

Asset Turnover (TTM)

AQB0.01x

LIMN0.00x

FCF Yield (TTM)

AQB-132.7%

LIMN-1.6%

Earnings Yield (TTM)

AQB-339.3%

LIMN-5.0%

Dividend Yield (TTM)

AQBN/A

LIMNN/A

Rule of 40

AQB-100.0

LIMN0.0

EV/GP/RG

AQBN/A

LIMNN/A

Ticker research

View AQB research View LIMN research

Metric	AQB AquaBounty Technologies Inc	LIMN Liminatus Pharma Inc
Market & Valuation
Market Cap	$5M	$253M
Enterprise Value	$4M	$251M
Price	$1.05	$3.76
P/E Ratio	N/A	N/A
P/S Ratio	3.78x	0.00x
EV/Sales	2.28x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.69x	17.43x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.49x	-62.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-18M	$-13M
FCF (TTM)	$-7M	$-4M
EPS (TTM)	-$3.56	-$12.94
ROE (TTM)	-4002.0%	0.0%
ROA (TTM)	-12997.0%	-62234.0%
ROIC (TTM)	-2623.0%	0.0%
Financial Health
Cash	$2M	$3M
Debt	$0	$1M
Net Cash/Debt	$2M	$2M
Current Ratio (TTM)	4.26x	1.12x
Quick Ratio (TTM)	4.22x	0.99x
Debt/Equity (TTM)	0.21x	4.80x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.45	0.75
52W Performance	-47.5%	-95.3%
YTD Performance	10.5%	-88.3%
% from 52W High	-48.5%	-97.3%
% from 52W Low	35.6%	14.3%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-132.7%	-1.6%
Earnings Yield (TTM)	-339.3%	-5.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AQB research	View LIMN research

Valuation

P/S Ratio

LIMN

0.00x

AQB

3.78x

EV/FCF

LIMN

-62.96x

AQB

-0.49x

Growth & revenue

Revenue Growth TTM

AQB

-100.0%

Forward Revenue Growth

AQB

0.0%

LIMN

0.0%

Profitability & performance

Gross Margin

AQB

0.0%

LIMN

0.0%

ROE

LIMN

0.0%

AQB

-4002.0%

FCF Yield %

LIMN

-1.6%

AQB

-132.7%

52-Week Performance

AQB

-47.5%

LIMN

-95.3%

Detailed metrics comparison

AQB

AquaBounty Technologies Inc

LIMN

Liminatus Pharma Inc

Market Cap

AQB$5M

LIMN$253M

Enterprise Value

AQB$4M

LIMN$251M

Price

AQB$1.05

LIMN$3.76

P/E Ratio

AQBN/A

LIMNN/A

P/S Ratio

AQB3.78x

LIMN0.00x

EV/Sales

AQB2.28x

LIMN0.00x

EV/EBITDA

AQB0.00x

LIMN0.00x

P/B Ratio

AQB1.69x

LIMN17.43x

P/FCF Ratio

AQBN/A

LIMNN/A

EV/FCF

AQB-0.49x

LIMN-62.96x

PEG Ratio

AQBN/A

LIMNN/A

Forward P/E (NTM)

AQBN/A

LIMNN/A

Forward P/S (NTM)

AQBN/A

LIMNN/A

Revenue (TTM)

AQB$0

LIMN$0

Revenue Growth (YoY)

AQB-100.0%

LIMNN/A

Forward Rev Growth

AQB0.0%

LIMN0.0%

Gross Margin (TTM)

AQB0.0%

LIMN0.0%

Operating Margin (TTM)

AQB0.0%

LIMN0.0%

EBITDA Margin (TTM)

AQB0.0%

LIMN0.0%

Net Margin (TTM)

AQB0.0%

LIMN0.0%

FCF Margin (TTM)

AQBN/A

LIMNN/A

Net Income (TTM)

AQB$-18M

LIMN$-13M

FCF (TTM)

AQB$-7M

LIMN$-4M

EPS (TTM)

AQB-$3.56

LIMN-$12.94

ROE (TTM)

AQB-4002.0%

LIMN0.0%

ROA (TTM)

AQB-12997.0%

LIMN-62234.0%

ROIC (TTM)

AQB-2623.0%

LIMN0.0%

Cash

AQB$2M

LIMN$3M

Debt

AQB$0

LIMN$1M

Net Cash/Debt

AQB$2M

LIMN$2M

Current Ratio (TTM)

AQB4.26x

LIMN1.12x

Quick Ratio (TTM)

AQB4.22x

LIMN0.99x

Debt/Equity (TTM)

AQB0.21x

LIMN4.80x

Debt/Assets (TTM)

AQB0.0%

LIMN0.0%

Interest Coverage (TTM)

AQBN/A

LIMNN/A

Net Debt/EBITDA (TTM)

AQB0.00x

LIMN0.00x

Beta

AQB1.45

LIMN0.75

52W Performance

AQB-47.5%

LIMN-95.3%

YTD Performance

AQB10.5%

LIMN-88.3%

% from 52W High

AQB-48.5%

LIMN-97.3%

% from 52W Low

AQB35.6%

LIMN14.3%

Asset Turnover (TTM)

AQB0.01x

LIMN0.00x

FCF Yield (TTM)

AQB-132.7%

LIMN-1.6%

Earnings Yield (TTM)

AQB-339.3%

LIMN-5.0%

Dividend Yield (TTM)

AQBN/A

LIMNN/A

Rule of 40

AQB-100.0

LIMN0.0

EV/GP/RG

AQBN/A

LIMNN/A

Ticker research

View AQB research View LIMN research

Metric	AQB AquaBounty Technologies Inc	LIMN Liminatus Pharma Inc
Market & Valuation
Market Cap	$5M	$253M
Enterprise Value	$4M	$251M
Price	$1.05	$3.76
P/E Ratio	N/A	N/A
P/S Ratio	3.78x	0.00x
EV/Sales	2.28x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.69x	17.43x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.49x	-62.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-18M	$-13M
FCF (TTM)	$-7M	$-4M
EPS (TTM)	-$3.56	-$12.94
ROE (TTM)	-4002.0%	0.0%
ROA (TTM)	-12997.0%	-62234.0%
ROIC (TTM)	-2623.0%	0.0%
Financial Health
Cash	$2M	$3M
Debt	$0	$1M
Net Cash/Debt	$2M	$2M
Current Ratio (TTM)	4.26x	1.12x
Quick Ratio (TTM)	4.22x	0.99x
Debt/Equity (TTM)	0.21x	4.80x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.45	0.75
52W Performance	-47.5%	-95.3%
YTD Performance	10.5%	-88.3%
% from 52W High	-48.5%	-97.3%
% from 52W Low	35.6%	14.3%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-132.7%	-1.6%
Earnings Yield (TTM)	-339.3%	-5.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AQB research	View LIMN research